Hy2Care Hits Milestone in Clinical Study of CartRevive

Hy2Care CartRevive Procedure

Hy2Care completed the second phase of its clinical trial with the treatment of the 46th patient using the CartRevive hydrogel implant. In early 2023, the Medical Ethical Review Committee of UMC Utrecht granted approval to continue the clinical study with an additional group of 36 patients, following a successful first safety group of 10 patients...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0